-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
-
Summary
-
POINT Biopharma Global Inc. quarterly Lessee, Operating Lease, Liability, to be Paid, Year Four history and change rate from Q2 2023 to Q3 2023.
- POINT Biopharma Global Inc. Lessee, Operating Lease, Liability, to be Paid, Year Four for the quarter ending 30 Sep 2023 was $769K.
Lessee, Operating Lease, Liability, to be Paid, Year Four, Quarterly (USD)